These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


125 related items for PubMed ID: 9045299

  • 1. Infectious complications of patients undergoing therapy for acute leukemia: current status and future prospects.
    Chanock SJ, Pizzo PA.
    Semin Oncol; 1997 Feb; 24(1):132-40. PubMed ID: 9045299
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. [Systemic fungal infections in immunocompromised patients].
    Zupanić-Krmek D, Nemet D.
    Acta Med Croatica; 2004 Feb; 58(4):251-61. PubMed ID: 15700680
    [Abstract] [Full Text] [Related]

  • 4. [Therapy of invasive organ mycoses in patients with systemic hematologic diseases].
    Karthaus M, Böhme A.
    Wien Med Wochenschr; 2001 Feb; 151(3-4):80-8. PubMed ID: 11789423
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Management of the febrile neutropenic patient.
    Picazo JJ, Association for Health Research and Development (ACINDES).
    Int J Antimicrob Agents; 2005 Dec; 26 Suppl 2():S120-2; discussion S133-40. PubMed ID: 16243492
    [Abstract] [Full Text] [Related]

  • 7. A prospective randomized trial of itraconazole vs fluconazole for the prevention of fungal infections in patients with acute leukemia and hematopoietic stem cell transplant recipients.
    Oren I, Rowe JM, Sprecher H, Tamir A, Benyamini N, Akria L, Gorelik A, Dally N, Zuckerman T, Haddad N, Fineman R, Dann EJ.
    Bone Marrow Transplant; 2006 Jul; 38(2):127-34. PubMed ID: 16751782
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Failure of fluconazole prophylaxis to reduce mortality or the requirement of systemic amphotericin B therapy during treatment for refractory acute myeloid leukemia: results of a prospective randomized phase III study. German AML Cooperative Group.
    Kern W, Behre G, Rudolf T, Kerkhoff A, Grote-Metke A, Eimermacher H, Kubica U, Wörmann B, Büchner T, Hiddemann W.
    Cancer; 1998 Jul 15; 83(2):291-301. PubMed ID: 9669812
    [Abstract] [Full Text] [Related]

  • 14. Infections in immunocompromised patients. I. Pathogenesis, etiology, and diagnosis.
    Klastersky J.
    Clin Ther; 1985 Jul 15; 8(1):90-9. PubMed ID: 3914372
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Antifungal prophylaxis for severely neutropenic chemotherapy recipients: a meta analysis of randomized-controlled clinical trials.
    Bow EJ, Laverdière M, Lussier N, Rotstein C, Cheang MS, Ioannou S.
    Cancer; 2002 Jun 15; 94(12):3230-46. PubMed ID: 12115356
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Febrile neutropenia. Etiology of infection, empirical treatment and prophylaxis.
    Eltahawy AT.
    Saudi Med J; 2003 Apr 15; 24(4):331-6. PubMed ID: 12754528
    [Abstract] [Full Text] [Related]

  • 20. Infections in patients with multiple myeloma.
    Nucci M, Anaissie E.
    Semin Hematol; 2009 Jul 15; 46(3):277-88. PubMed ID: 19549580
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 7.